Applied Visual Sciences, Inc. (APVS)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
APVS steht fuer Applied Visual Sciences, Inc., ein Technology-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Bewertet mit 44/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 16. März 2026Applied Visual Sciences, Inc. (APVS) Technologieprofil & Wettbewerbsposition
Applied Visual Sciences, Inc. develops computer-vision solutions for aviation security and healthcare, focusing on automated threat recognition and diagnostic imaging. Their Signature Mapping platform and PinPoint technology target critical needs in security and medical sectors, operating in a competitive software application landscape.
Investmentthese
Applied Visual Sciences, Inc. operates in niche markets within the security and healthcare sectors, leveraging computer-vision technology. With a market capitalization of $0.00B and a negative P/E ratio of -0.01, the company's financial performance is currently challenged. The company's beta of -10.35 suggests high volatility relative to the market. Growth catalysts depend on successful commercialization of their Signature Mapping platform and PinPoint technology. Key risks include limited financial resources, intense competition, and the need for regulatory approvals. Investors should closely monitor the company's ability to secure contracts and expand its market presence.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market Cap: $0.00B indicating a micro-cap company with limited financial resources.
- P/E Ratio: -0.01 reflecting negative earnings and potential financial instability.
- Beta: -10.35 suggesting high volatility and potential for significant price swings.
- Dividend Yield: None indicating no current income for investors.
- Focus on computer-vision detection solutions for aviation/homeland security and healthcare markets, positioning them in high-growth sectors.
Wettbewerber & Vergleichsunternehmen
Staerken
- Proprietary computer-vision technology.
- Focus on high-growth markets (security and healthcare).
- Established Signature Mapping platform.
- Specialized expertise in target recognition and diagnostic imaging.
Schwaechen
- Limited financial resources.
- Small employee base (3 employees).
- Dependence on a few key products.
- Negative P/E ratio indicating unprofitability.
Katalysatoren
- Ongoing: Potential contracts with airports for PinPoint technology.
- Ongoing: Adoption of Signature Mapping platform in healthcare.
- Upcoming: Potential strategic partnerships with industry players.
- Upcoming: Securing government contracts for homeland security applications.
Risiken
- Ongoing: Limited financial resources.
- Potential: Intense competition from larger companies.
- Potential: Rapid technological advancements.
- Potential: Regulatory hurdles and compliance requirements.
- Ongoing: Low trading volume and liquidity due to OTC listing.
Wachstumschancen
- Expansion in Aviation Security: The increasing need for enhanced security measures at airports globally presents a significant growth opportunity for APVS's PinPoint technology. The market for aviation security systems is projected to reach billions of dollars by 2030. Securing contracts with major airports could drive substantial revenue growth for APVS.
- Adoption in Healthcare Diagnostics: The Signature Mapping platform has the potential to revolutionize diagnostic radiology and pathology. As healthcare providers increasingly adopt AI-powered diagnostic tools, APVS can capitalize on the growing demand for accurate and efficient detection systems. The market for AI in healthcare diagnostics is expected to grow rapidly over the next decade.
- Strategic Partnerships: Forming strategic alliances with established players in the security and healthcare industries can accelerate market penetration for APVS. Partnering with companies that have existing distribution channels and customer relationships can provide access to new markets and customers.
- Government Contracts: Securing government contracts for homeland security applications can provide a stable revenue stream for APVS. Government agencies are increasingly investing in advanced security technologies to protect critical infrastructure and public spaces. APVS's PinPoint technology is well-suited for these applications.
- International Expansion: Expanding into international markets can unlock new growth opportunities for APVS. The demand for advanced security and healthcare solutions is growing globally, particularly in emerging markets. Adapting its products to meet the specific needs of different regions can drive international sales.
Chancen
- Expansion into new geographic markets.
- Strategic partnerships with industry leaders.
- Securing government contracts.
- Adoption of AI in healthcare diagnostics.
Risiken
- Intense competition from larger companies.
- Rapid technological advancements.
- Regulatory hurdles and compliance requirements.
- Economic downturn affecting customer spending.
Wettbewerbsvorteile
- Proprietary computer-vision algorithms.
- Patented Signature Mapping platform technology.
- Specialized expertise in aviation security and healthcare diagnostics.
- Established relationships with key customers and partners.
Ueber APVS
Founded in 1989 and based in Leesburg, Virginia, Applied Visual Sciences, Inc. (APVS) is a software technology company specializing in computer-vision detection solutions. Originally named Guardian Technologies International, Inc., the company rebranded in July 2010 to reflect its focus on advanced visual technologies. APVS designs and develops integrated information management technology products and services for corporations and governmental agencies, primarily targeting the aviation/homeland security and healthcare markets. Their core offerings include PinPoint, an intelligent computer-vision system for automated target recognition of threats like guns and explosives in baggage and building security. Additionally, APVS provides the Signature Mapping platform technology, which is used in diagnostic radiology and pathology. This platform underpins the Signature Mapping Detection System, a hardware-software solution for infectious disease applications, and specific software like Signature Mapping Tuberculosis Detection and Signature Mapping Breast Cancer Detection. APVS markets its products globally through direct sales and indirect distribution channels.
Was das Unternehmen tut
- Develop computer-vision detection solutions.
- Design software for aviation/homeland security.
- Create imaging technologies for healthcare markets.
- Offer PinPoint technology for threat detection.
- Provide Signature Mapping platform for diagnostic radiology.
- Offer Signature Mapping Detection System for infectious disease applications.
Geschaeftsmodell
- Direct sales of software and hardware solutions.
- Indirect distribution through channel partners.
- Licensing of Signature Mapping platform technology.
- Service and maintenance contracts for installed systems.
Branchenkontext
Applied Visual Sciences, Inc. operates in the software application industry, which is characterized by rapid technological advancements and intense competition. The market for computer-vision solutions in security and healthcare is growing, driven by increasing demand for automated threat detection and diagnostic accuracy. Key competitors include companies offering similar imaging and detection technologies. APVS's success depends on its ability to innovate and differentiate its products in this competitive landscape.
Wichtige Kunden
- Airports and transportation security agencies.
- Hospitals and diagnostic imaging centers.
- Government agencies focused on homeland security.
- Research institutions studying infectious diseases.
Finanzdaten
Chart & Info
Applied Visual Sciences, Inc. (APVS) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
-
Comparing Applied Visual Sciences (OTCMKTS:APVS) & Axon Enterprise (NASDAQ:AXON)
defenseworld.net · 10. März 2026
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer APVS.
Kursziele
Wall-Street-Kurszielanalyse fuer APVS.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von APVS auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: William J. Donovan
CEO
William J. Donovan serves as the CEO of Applied Visual Sciences, Inc., overseeing the company's strategic direction and operations. With a focus on leveraging technology for security and healthcare applications, Donovan manages a small team of 3 employees. His background likely includes experience in technology management and business development. Further details on his specific career history and educational credentials are not available.
Erfolgsbilanz: Given the limited information available, it is difficult to assess William J. Donovan's specific track record at Applied Visual Sciences, Inc. However, as CEO, he is responsible for guiding the company's product development, market expansion, and financial performance. The success of APVS's Signature Mapping platform and PinPoint technology will be key indicators of his leadership.
APVS OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that Applied Visual Sciences, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be required to provide regular financial reports. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, which can increase investment risk.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement.
- Lack of regulatory oversight.
- Verify the company's financial statements.
- Assess the company's business model and competitive position.
- Research the background of the company's management team.
- Evaluate the company's regulatory compliance.
- Understand the risks associated with investing in OTC stocks.
- Check for any legal or regulatory actions against the company.
- Determine the company's ownership structure.
- Longevity in the market (founded in 1989).
- Focus on specialized technology solutions.
- Patented Signature Mapping platform technology.
- Targeting high-growth markets (security and healthcare).
APVS Technology Aktien-FAQ
What are the key factors to evaluate for APVS?
Applied Visual Sciences, Inc. (APVS) currently holds an AI score of 44/100, indicating low score. Key strength: Proprietary computer-vision technology.. Primary risk to monitor: Ongoing: Limited financial resources.. This is not financial advice.
How frequently does APVS data refresh on this page?
APVS prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven APVS's recent stock price performance?
Recent price movement in Applied Visual Sciences, Inc. (APVS) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary computer-vision technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider APVS overvalued or undervalued right now?
Determining whether Applied Visual Sciences, Inc. (APVS) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying APVS?
Before investing in Applied Visual Sciences, Inc. (APVS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding APVS to a portfolio?
Potential reasons to consider Applied Visual Sciences, Inc. (APVS) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Proprietary computer-vision technology.. Additionally: Focus on high-growth markets (security and healthcare).. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of APVS?
Yes, most major brokerages offer fractional shares of Applied Visual Sciences, Inc. (APVS) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track APVS's earnings and financial reports?
Applied Visual Sciences, Inc. (APVS) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for APVS earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Limited information available on the company's financials and operations.
- OTC listing increases investment risk.
- AI analysis pending for APVS.